Evidence map›Paper›PMID 24433835›Full record

ArticleBiomaterials2014

Myocardial contraction and hyaluronic acid mechanotransduction in epithelial-to-mesenchymal transformation of endocardial cells.

Mary Kathryn Sewell-Loftin, Daniel M DeLaughter, Jon R Peacock, Christopher B Brown, H Scott Baldwin, Joey V Barnett, W David Merryman

Abstract read
In one paragraph

Article in Biomaterials, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. In vitro models of aortic valve calcification: solidifying a system.Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mary Kathryn Sewell-LoftinDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN 37232, USA.
Daniel M DeLaughterDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN 37232, USA.
Jon R PeacockDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN 37232, USA.
Christopher B BrownDepartment of Pediatrics, Division of Cardiology, Vanderbilt University, Nashville, TN 37232, USA.
H Scott BaldwinDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN 37232, USA; Department of Pediatrics, Division of Cardiology, Vanderbilt University, Nashville, TN 37232, USA.
Joey V BarnettDepartment of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA.
W David MerrymanDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN 37232, USA. Electronic address: david.merryman@vanderbilt.edu.
Vanderbilt University · US

Funding

Training Program in Stem Cell and Regenerative Developmental BiologyT32HD007502 · NICHD · VANDERBILT UNIVERSITY · PI WRIGHT, CHRISTOPHER V · 1997 to 2022
$5.4M
Developmental Determinants of Cardiovascular DiseaseT32HL105334 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BALDWIN, H SCOTT · 2011 to 2021
$4.3M
SysCODE Heart Valve Design and EngineeringRL1HL092551 · NHLBI · VANDERBILT UNIVERSITY · PI BALDWIN, H SCOTT · 2007 to 2011
$2.8M
Tie Tek Modulation of Cardiac DevelopmentR01HL118386 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BALDWIN, H SCOTT · 2013 to 2017
$2.1M
Serotonergic Receptor Targeted Therapy for Degenerative Aortic Valve DiseaseR01HL115103 · NHLBI · VANDERBILT UNIVERSITY · PI MERRYMAN, WILLIAM D · 2013 to 2016
$1.5M
TGF-beta1 activity in the aortic valveK25HL094707 · NHLBI · VANDERBILT UNIVERSITY · PI MERRYMAN, WILLIAM D · 2009 to 2013
$725k
NHLBI NIH HHS HL092551NHLBI NIH HHS HL094707NHLBI NIH HHS K25 HL094707NHLBI NIH HHS R01 HL115103NHLBI NIH HHS R01 HL118386NHLBI NIH HHS RL1 HL092551NHLBI NIH HHS T32 HL105334NICHD NIH HHS T32 HD007502
6 · The paper itself

Abstract

Epithelial-to-mesenchymal transition (EMT) of endocardial cells is a critical initial step in the formation of heart valves. The collagen gel in vitro model has provided significant information on the role of growth factors regulating EMT but has not permitted investigation of mechanical factors. Therefore we sought to develop a system to probe the effects of mechanical inputs on endocardial EMT by incorporating hyaluronic acid (HA), the primary component of endocardial cushions in developing heart valves, into the gel assay. This was achieved using a combination collagen and crosslinkable methacrylated HA hydrogel (Coll-MeHA). Avian atrioventricular canal explants on Coll-MeHA gels showed increased numbers of transformed cells. Analysis of the mechanical properties of Coll-MeHA gels shows that stiffness does not directly affect EMT. Hydrogel deformation from the beating myocardium of explants directly led to higher levels of regional gel deformation and larger average strain magnitudes associated with invaded cells on Coll-MeHA gels. Inhibition of this contraction reduced EMT on all gel types, although to a lesser extent on Coll-MeHA gels. Using the system we have developed, which permits the manipulation of mechanical factors, we have demonstrated that active mechanical forces play a role in the regulation of endocardial EMT.

Indexed as

AnimalsCell ProliferationChickensCollagen Type ICross-Linking ReagentsEndocardiumEpithelial-Mesenchymal TransitionHyaluronic AcidMechanotransduction, CellularMethacrylatesMyocardial ContractionSignal TransductionTissue ScaffoldsCollagen Type ICross-Linking ReagentsHyaluronic AcidMethacrylatesCollagenEpithelial-to-mesenchymal transition (EMT)Heart valveHyaluronic acidMechanical properties

Identifiers

PMID24433835
PMCPMC3950274
OpenAlexW2017689650

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.